We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+9.5%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.76B
AUM Growth
+$16.7M
Cap. Flow
-$84.9M
Cap. Flow %
-4.82%
Top 10 Hldgs %
24.37%
Holding
275
New
15
Increased
54
Reduced
181
Closed
13

Top Buys

Rank Stock Value
1
RBA icon
RB Global
RBA
+$12.2M
2
PCRX icon
Pacira BioSciences
PCRX
+$12.2M
3
DOCS icon
Doximity
DOCS
+$8.19M
4
ESTA icon
Establishment Labs
ESTA
+$6.27M
5
COLB icon
Columbia Banking Systems
COLB
+$5M

Top Sells

Rank Stock Value
1
IAA
IAA, Inc. Common Stock
IAA
+$17.7M
2
MED icon
Medifast
MED
+$17.2M
3
ALBO
Albireo Pharma Inc
ALBO
+$11.1M
4
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$6.11M
5
WNS
WNS Holdings
WNS
+$5.97M

Sector Composition

Rank Sector Weight
1 Healthcare 27.26%
2 Technology 26.93%
3 Industrials 17.12%
4 Consumer Discretionary 9.62%
5 Communication Services 6.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GNTY
226
DELISTED
Guaranty Bancshares
GNTY
$1.27M 0.07%
45,512
-32,086
-41% -$1.01M
MP icon
227
MP Materials
MP
$9.73B
$1.27M 0.07%
44,932
+2,218
+5% +$67.1K
DVN icon
228
Devon Energy
DVN
$49.9B
$1.26M 0.07%
24,940
-286
-1% -$16.3K
MIRM icon
229
Mirum Pharmaceuticals
MIRM
$6.02B
$1.26M 0.07%
+52,295
New +$1.19M
PBYI icon
230
Puma Biotechnology
PBYI
$442M
$1.14M 0.06%
367,497
-15,721
-4% -$59.3K
GBCI icon
231
Glacier Bancorp
GBCI
$6.35B
$1.12M 0.06%
26,671
+354
+1% +$16.2K
TTD icon
232
Trade Desk
TTD
$6.29B
$1.09M 0.06%
17,946
-123
-0.7% -$6.55K
TDY icon
233
Teledyne Technologies
TDY
$32B
$1.05M 0.06%
2,339
-19
-0.8% -$8.05K
COLM icon
234
Columbia Sportswear
COLM
$2.92B
$1.02M 0.06%
11,313
-149
-1% -$13.4K
BRK.B icon
235
Berkshire Hathaway Class B
BRK.B
$1.14T
$912K 0.05%
2,955
– –
DENN
236
DELISTED
Denny's
DENN
$850K 0.05%
76,187
+413
+0.5% +$4.8K
SMID icon
237
Smith-Midland
SMID
$146M
$794K 0.05%
42,329
+159
+0.4% +$3.16K
ABBV icon
238
AbbVie
ABBV
$438B
$791K 0.04%
4,961
-20
-0.4% -$3.06K
LLY icon
239
Eli Lilly
LLY
$1.1T
$683K 0.04%
1,990
-150
-7% -$50.6K
URGN icon
240
UroGen Pharma
URGN
$2.26B
$676K 0.04%
73,205
+274
+0.4% +$2.52K
NOTV
241
DELISTED
Inotiv
NOTV
$643K 0.04%
148,454
+8,695
+6% +$55.4K
CVX icon
242
Chevron
CVX
$382B
$610K 0.03%
3,737
– –
ABT icon
243
Abbott
ABT
$188B
$545K 0.03%
5,386
– –
BRK.A icon
244
Berkshire Hathaway Class A
BRK.A
$1.14T
$466K 0.03%
1
– –
AAPL icon
245
Apple
AAPL
$4.5T
$462K 0.03%
2,800
– –
YMAB
246
DELISTED
Y-mAbs Therapeutics
YMAB
$448K 0.03%
89,480
+2,390
+3% +$9.76K
SYY icon
247
Sysco
SYY
$40.1B
$440K 0.03%
5,702
-25
-0.4% -$1.92K
J icon
248
Jacobs Solutions
J
$17.2B
$417K 0.02%
4,286
– –
XOM icon
249
ExxonMobil
XOM
$662B
$410K 0.02%
3,743
-460
-11% -$50.9K
WMT icon
250
Walmart Inc
WMT
$897B
$397K 0.02%
8,073
– –
7 8 9
10
11

Similar funds

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM

Rice Hall James & Associates's Q1 2023 Portfolio in Review

As of Q1 2023, Rice Hall James & Associates held 275 positions worth $1.76B, up 0.96% from $1.74B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Rice Hall James & Associates withdrew a net $84.9M in Q1 2023, closing 13 positions and reducing 181 holdings. Its most notable exit was IAA, Inc. Common Stock, an estimated $17.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 26% a quarter earlier, followed by Technology and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in RB Global worth $11.7M.

  • Rice Hall James & Associates's largest Q1 2023 buy was RB Global: 207,333 shares worth $11.7M.
  • Rice Hall James & Associates added most to Pacira BioSciences in Q1 2023, an estimated $12.2M increase.
  • Rice Hall James & Associates's biggest Q1 2023 reduction was Medifast, cutting an estimated $17.2M.
  • Rice Hall James & Associates fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $17.7M.
  • Rice Hall James & Associates's ten largest holdings make up 24% of its $1.76B portfolio in Q1 2023.
  • Rice Hall James & Associates opened 15 new positions and closed 13 in Q1 2023.
  • Rice Hall James & Associates's portfolio value rose 0.96% quarter-over-quarter to $1.76B.

Based on Rice Hall James & Associates's 13F filing for Q1 2023, filed 12 May 2023.